ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
Upstream Bio Inc

Upstream Bio Inc (UPB)

10.39
-0.38
(-3.53%)
終了 1月25日 6:00AM
10.39
0.00
( 0.00% )
プレマーケット: 9:44PM

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

主要統計と詳細

通貨
10.39
買値
8.80
売値
10.90
出来高
9
0.00 日の範囲 0.00
8.40 52 週間の範囲 29.35
時価総額
前日終値
10.39
始値
-
時刻
1
@
8.71
最終取引時間
20:51:28
財務取引量
-
VWAP
-
平均取引量 (3 か月)
329,346
発行済株式数
53,596,601
配当利回り
-
PER
-14.56
1 株当たり利益 (EPS)
-0.71
歳入
2.38M
純利益
-38.26M

Upstream Bio Inc について

Upstream Bio is a clinical-stage biotechnology company developing treatments for inflammatory diseases, with an initial focus on severe respiratory disorders. We are developing verekitug, the only known antagonist currently in clinical development that targets the receptor for Thymic Stromal Lymphop... Upstream Bio is a clinical-stage biotechnology company developing treatments for inflammatory diseases, with an initial focus on severe respiratory disorders. We are developing verekitug, the only known antagonist currently in clinical development that targets the receptor for Thymic Stromal Lymphopoietin ("TSLP"), a cytokine which is a clinically validated driver of inflammatory response positioned upstream of multiple signaling cascades that affect a variety of immune mediated diseases. Preclinical and clinical data to date demonstrate verekitug's highly potent inhibition of the TSLP receptor, which we believe will translate to a differentiated product profile, including improved clinical outcomes, substantially extended dosing intervals and the potential to treat a broad spectrum of patients. 詳細を表示

セクター
Pharmaceutical Preparations
業界
Pharmaceutical Preparations
ウェブサイト
本社
Wilmington, Delaware, USA
設立
-
Upstream Bio Inc is listed in the Pharmaceutical Preparations sector of the ナスダック市場 with ticker UPB. The last closing price for Upstream Bio was US$10.39. Over the last year, Upstream Bio shares have traded in a share price range of US$ 8.40 to US$ 29.35.

Upstream Bio currently has 53,596,601 shares in issue. The market capitalisation of Upstream Bio is US$556.87 million. Upstream Bio has a price to earnings ratio (PE ratio) of -14.56.

UPB 最新ニュース

Upstream Bio to Present at the 43rd Annual J.P. Morgan Healthcare Conference

WALTHAM, Mass., Jan. 06, 2025 (GLOBE NEWSWIRE) -- Upstream Bio, Inc. (Nasdaq: UPB), a clinical-stage company developing treatments for inflammatory diseases, with an initial focus on severe...

Upstream Bio Appoints Allison Ambrose as General Counsel

WALTHAM, Mass., Dec. 17, 2024 (GLOBE NEWSWIRE) -- Upstream Bio, Inc. (Nasdaq: UPB), a clinical-stage company developing treatments for inflammatory diseases, with an initial focus on severe...

Upstream Bio Announces Addition to Russell 2000® Index

WALTHAM, Mass., Dec. 16, 2024 (GLOBE NEWSWIRE) -- Upstream Bio, Inc. (Nasdaq: UPB), a clinical-stage company developing treatments for inflammatory diseases, with an initial focus on severe...

Upstream Bio to Participate in the Piper Sandler 36th Annual Healthcare Conference

WALTHAM, Mass., Nov. 21, 2024 (GLOBE NEWSWIRE) -- Upstream Bio, Inc. (Nasdaq: UPB), a clinical-stage company developing treatments for inflammatory diseases, with an initial focus on severe...

Upstream Bio Reports Third Quarter 2024 Financial Results and Recent Business Highlights

– Advancing Phase 2 clinical trials of verekitug in patients with severe asthma and CRSwNP – – Commenced startup for a Phase 2 clinical trial in COPD; on track for first patient to be dosed in H2...

期間 †前日比前日比 %始値高値安値平均出来高VWAP
1-0.62-5.6312443233411.0111.348.431104810.69929369CS
4-8.31-44.438502673818.718.94998.426323313.43603249CS
12-14.37-58.037156704424.7629.358.432934618.40112511CS
26-11.11-51.674418604721.529.358.435104219.93800309CS
52-11.11-51.674418604721.529.358.435104219.93800309CS
156-11.11-51.674418604721.529.358.435104219.93800309CS
260-11.11-51.674418604721.529.358.435104219.93800309CS

UPB - Frequently Asked Questions (FAQ)

What is the current Upstream Bio share price?
The current share price of Upstream Bio is US$ 10.39
How many Upstream Bio shares are in issue?
Upstream Bio has 53,596,601 shares in issue
What is the market cap of Upstream Bio?
The market capitalisation of Upstream Bio is USD 556.87M
What is the 1 year trading range for Upstream Bio share price?
Upstream Bio has traded in the range of US$ 8.40 to US$ 29.35 during the past year
What is the PE ratio of Upstream Bio?
The price to earnings ratio of Upstream Bio is -14.56
What is the cash to sales ratio of Upstream Bio?
The cash to sales ratio of Upstream Bio is 234.01
What is the reporting currency for Upstream Bio?
Upstream Bio reports financial results in USD
What is the latest annual turnover for Upstream Bio?
The latest annual turnover of Upstream Bio is USD 2.38M
What is the latest annual profit for Upstream Bio?
The latest annual profit of Upstream Bio is USD -38.26M
What is the registered address of Upstream Bio?
The registered address for Upstream Bio is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808
What is the Upstream Bio website address?
The website address for Upstream Bio is www.upstreambio.com
Which industry sector does Upstream Bio operate in?
Upstream Bio operates in the PHARMACEUTICAL PREPARATIONS sector

ムーバー

すべて表示
  • 出来高
  • 値上がり率
  • 値下がり率
銘柄コード株価出来高
JGAurora Mobile Ltd
US$ 18.13
(201.56%)
9.53M
AKROAkero Therapeutics Inc
US$ 54.50
(108.17%)
2.56M
ONCOOnconetix Inc
US$ 0.8876
(84.92%)
52.16M
MLGOMicroAlgo Inc
US$ 2.62
(72.37%)
29.08M
CDZIPCadiz Inc
US$ 28.84
(59.96%)
30
ALLKAllakos Inc
US$ 0.2986
(-75.32%)
2.9M
ATLOAmes National Corporation
US$ 7.15
(-59.74%)
62
NODKNI Holdings Inc
US$ 6.01
(-58.58%)
7
VERUVeru Inc
US$ 0.6533
(-46.01%)
4.66M
NXUNXU Inc
US$ 0.3989
(-35.24%)
788.41k
NVDANVIDIA Corporation
US$ 126.29
(-11.45%)
53.23M
ONCOOnconetix Inc
US$ 0.8877
(84.94%)
52.27M
TVGNTevogen Bio Holdings Inc
US$ 1.95
(44.44%)
29.35M
MLGOMicroAlgo Inc
US$ 2.62
(72.37%)
29.11M
HWHHWH International Inc
US$ 0.3599
(25.10%)
25.57M

最近閲覧した銘柄

Delayed Upgrade Clock